Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bile Acid–Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside
Min Yang, Yu Gu, Lingfeng Li, et al.
Nutrients (2021) Vol. 13, Iss. 9, pp. 3143-3143
Open Access | Times Cited: 122

Showing 1-25 of 122 citing articles:

The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease
John P. Thomas, Dezső Módos, Simon Rushbrook, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 101
Interactive Relationships between Intestinal Flora and Bile Acids
Xiaohua Guo, Edozie Samuel Okpara, Wanting Hu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8343-8343
Open Access | Times Cited: 93
Gut Microbiome–Brain Alliance: A Landscape View into Mental and Gastrointestinal Health and Disorders
Janet M. Sasso, Ramy M. Ammar, Rumiana Tenchov, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 10, pp. 1717-1763
Open Access | Times Cited: 92
Herba Origani alleviated DSS-induced ulcerative colitis in mice through remolding gut microbiota to regulate bile acid and short-chain fatty acid metabolisms
Zuoting Yu, Dinggang Li, Hongxiang Sun
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114409-114409
Open Access | Times Cited: 57
New and Emerging Treatments for Inflammatory Bowel Disease
Masaaki Higashiyama, Ryota Hokari
Digestion (2022) Vol. 104, Iss. 1, pp. 74-81
Open Access | Times Cited: 67
Gut microbiome-produced metabolites in pigs: a review on their biological functions and the influence of probiotics
Robie Vasquez, Ju Kyoung Oh, Ji Hoon Song, et al.
Journal of Animal Science and Technology (2022) Vol. 64, Iss. 4, pp. 671-695
Open Access | Times Cited: 62
Pre-Administration of Berberine Exerts Chemopreventive Effects in AOM/DSS-Induced Colitis-Associated Carcinogenesis Mice via Modulating Inflammation and Intestinal Microbiota
Jiaqiang Deng, Lili Zhao, Xieyong Yuan, et al.
Nutrients (2022) Vol. 14, Iss. 4, pp. 726-726
Open Access | Times Cited: 39
Microbiome and metabolome in inflammatory bowel disease
Khushboo G. Upadhyay, Devendra Desai, Tester F. Ashavaid, et al.
Journal of Gastroenterology and Hepatology (2022) Vol. 38, Iss. 1, pp. 34-43
Closed Access | Times Cited: 38
The role of intestinal microbes on intestinal barrier function and host immunity from a metabolite perspective
Yi-Feng Fu, Jin Lyu, Shuangshuang Wang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 38
Potential effects and mechanism of flavonoids extract of Callicarpa nudiflora Hook on DSS-induced colitis in mice
Keyi Nong, Xinyun Qin, Zhineng Liu, et al.
Phytomedicine (2024) Vol. 128, pp. 155523-155523
Closed Access | Times Cited: 13
Microbial Dysbiosis Linked to Metabolic Dysfunction-Associated Fatty Liver Disease in Asians: Prevotella copri Promotes Lipopolysaccharide Biosynthesis and Network Instability in the Prevotella Enterotype
Heng Yuan, Xuangao Wu, Xichun Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2183-2183
Open Access | Times Cited: 12
Biomarkers for Health Functional Foods in Metabolic Dysfunction-Associated Steatotic Liver Disorder (MASLD) Prevention: An Integrative Analysis of Network Pharmacology, Gut Microbiota, and Multi-Omics
Heng Yuan, Eun-Soo Jung, Soo-Wan Chae, et al.
Nutrients (2024) Vol. 16, Iss. 18, pp. 3061-3061
Open Access | Times Cited: 8
Advances in Fecal Microbiota Transplantation for Gut Dysbiosis‐Related Diseases
Shijiao Hou, Jiachen Yu, Yongshuang Li, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Gut Microbiota Serves as a Crucial Independent Biomarker in Inflammatory Bowel Disease (IBD)
Bharti Sharma, George Agriantonis, Kate Twelker, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2503-2503
Open Access | Times Cited: 1
The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
Yulin Zhang, Zhen-Jiao Li, Hong-Zhong Gou, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 37
The Toxic Effects of Endocrine Disrupting Chemicals (EDCs) on Gut Microbiota: Bisphenol A (BPA) A Review
Ioannis Alexandros Charitos, Skënder Topi, R. Candela, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2022) Vol. 22, Iss. 7, pp. 716-727
Closed Access | Times Cited: 33
Bifidobacterium longum CECT 7894 Improves the Efficacy of Infliximab for DSS-Induced Colitis via Regulating the Gut Microbiota and Bile Acid Metabolism
Fangfei Xiao, Fang Dong, Xiaolu Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 32
Bile Acids: Key Players in Inflammatory Bowel Diseases?
Aïcha Kriaa, Vincent Mariaule, Amin Jablaoui, et al.
Cells (2022) Vol. 11, Iss. 5, pp. 901-901
Open Access | Times Cited: 31
Eucommia bark/leaf extract improves HFD-induced lipid metabolism disorders via targeting gut microbiota to activate the Fiaf-LPL gut-liver axis and SCFAs-GPR43 gut-fat axis
Zhineng Wang, Yin Sun, Yewen Han, et al.
Phytomedicine (2023) Vol. 110, pp. 154652-154652
Open Access | Times Cited: 21
Cryptotanshinone alleviates radiation‐induced lung fibrosis via modulation of gut microbiota and bile acid metabolism
Zhanhong Li, Yun‐Heng Shen, Jiayun Xin, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 10, pp. 4557-4571
Closed Access | Times Cited: 21
The human gut phageome: composition, development, and alterations in disease
Yingying Zhang, Ran Wang
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 17
Liver’s influence on the brain through the action of bile acids
Xin Yi Yeo, Tan Li, Woo Ri Chae, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 16
Postbiotics: An alternative and innovative intervention for the therapy of inflammatory bowel disease
Kavita Kavita, Hari Om, Umesh Chand, et al.
Microbiological Research (2023) Vol. 279, pp. 127550-127550
Closed Access | Times Cited: 16
Synbiotics containing sea buckthorn polysaccharides ameliorate DSS-induced colitis in mice via regulating Th17/Treg homeostasis through intestinal microbiota and their production of BA metabolites and SCFAs
Mingyou Yuan, Lili Chang, Pan Gao, et al.
International Journal of Biological Macromolecules (2024) Vol. 276, pp. 133794-133794
Closed Access | Times Cited: 7
Exploring the role of a novel postbiotic bile acid: Interplay with gut microbiota, modulation of the farnesoid X receptor, and prospects for clinical translation
Beibei Wang, Dong Woo Han, Xin‐Yue Hu, et al.
Microbiological Research (2024) Vol. 287, pp. 127865-127865
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top